• Represented CutisPharma, Inc., a specialty pharmaceutical company that develops and commercializes compounding kits that help patients who are unable to swallow conventional oral dosage forms such as tablets and capsules and recently launched FDA-approved drug Firvanq, in its sale to NovaQuest Capital Management, L.L.C. 
• Represented leading healthcare data analytics company Inovalon Holdings Inc. (INOV:Nasdaq) in its $1.2B acquisition of ABILITY Network, a cloud-based software-as-a-service healthcare technology company. 
• Represented information technology corporation Dell Technologies in its $145.8 million sale of Mozy, Inc. to data protection company Carbonite, Inc. (NASDAQ:CARB). 
• Represented the shareholders of the Northern Harvest Sea Farms group, a group of aquaculture companies engaged in the production of farmed Atlantic salmon in eastern Canada, in its sale to Marine Harvest (OSE:MHG), one of the largest seafood companies in the world and the world’s largest producer of Atlantic salmon, for CAD 315 million. 
• Advised Crane Co. (NYSE: CR), a diversified manufacturer of highly engineered industrial products, in its recent $800 million acquisition of Crane & Co., Inc. from private equity firm Lindsay Goldberg and other shareholders. 
• Represented Body Labs, a creator of 3D body model technology, in its acquisition by Amazon (NASDAQ: AMZN). 
• Represented computer-aided engineering company Exa Corporation (NASDAQ:EXA) in its $400M sale to French software company Dassault Systèmes.
• Represented Curriculum Associates, a publisher of research-based print and online instructional materials, in a capital partnership with Berkshire Partners
• Represented Dragon Innovation, a provider of manufacturing solutions that help new hardware developers go from prototype to full production, in its sale to Avnet (NYSE: AVT).
• Represented Good Start Genetics, a privately-held molecular diagnostics company focused on preimplantation and genetic carrier screening, in a merger with genetic information company Invitae Corporation (NYSE: NVTA).
• Represented Mill Road Capital II, L.P. and its portfolio company, Skullcandy Inc., in the $85M sale of Skullcandy’s ASTRO Gaming headset business to Logitech (NASDAQ: LOGI), a Swiss public company offering music, gaming, video and computing products.
• Represented The Boston Consulting Group, one of the leading global management consulting firms, in its acquisition of assets of world-class digital design lab MAYA Design.
• Represented security orchestration and automation company Komand, Inc. in its sale to corporate network security company Rapid7 (NASDAQ: RPD).
• Represented Lux Research, a leading provider of intelligence and consulting services, in its acquisition and growth investment by private equity firm Bregal Sagemount
• Represented International Data Group, Inc. (IDG) and its operating subsidiaries International Data Corporation and IDG Communications, Inc. in connection with the acquisition, in two separate transactions, of IDG and of IDG’s extensive portfolio of venture capital holdings by a consortium of buyers led by China Oceanwide Holdings Group Co., Ltd and IDG Capital Partners.
• Represented L2, Inc., a business intelligence firm that benchmarks the digital performance of consumer brands, in its acquisition by Gartner, Inc. (NYSE: IT), the world’s leading information technology research and advisory company.
• Represented Living Proof, Inc., the innovative premium hair care business that solves hair problems by using breakthrough science, in its acquisition by Unilever. Living Proof will be part of Unilever’s Prestige portfolio.
• Represented Mill Road Capital, a private investment firm focused on investing in publicly traded micro-cap companies in the U.S. and Canada, in the going private acquisition of Skullcandy, Inc. (Nasdaq; SKUL), a creator of world-class audio experiences through its Skullcandy and Astro Gaming brands, after a contested process. 
• Represented Immunetics, Inc., a diagnostics company focused on developing specialized tests for infectious diseases, in its sale to Oxford Immunotec Global PLC (Nasdaq:OXFD).
• Represented Dell EMC in the sale of EMC’s enterprise content division, including Documentum and other leading enterprise content management solutions, to Open Text Corporation (NASDAQ:OTEX) (TSX: OTC), a global leader in enterprise information management, for $1.62 billion.
• Represented CloudLock, Inc., an industry leader in cloud security for multiple platforms, in its $300 million cash acquisition by Cisco Systems.
• Represented Staples, Inc. (NYSE: SPLS), a world-class provider of products and services that serve the needs of business customers and consumers, in the sale of its Staples Print Solutions business to Taylor Communications, Inc.
• Represented Interconnect Systems, Inc., a designer and manufacturer of high density silicon packaging with advanced interconnect technologies, in its acquisition by Molex LLC, a leading global manufacturer of electronic solutions.
• Represented Topokine Therapeutics, Inc., a privately held, clinical-stage biotechnology company focused on developing topical medicines for fat reduction, in its acquisition by Allergan plc (NYSE: AGN).
• Represented Pegasystems Inc. (NASDAQ: PEGA), the software company empowering the world’s leading enterprises with strategic business applications, in its acquisition of OpenSpan, Inc., a privately held software provider of robotic process automation and workforce analytics software.
• Represented Resilient Systems, Inc., the provider of the industry standard in Incident Response Platform (IRP), in its acquisition by IBM in a cash transaction.
• Represented SunSetter Products Limited Partnership in its sale to Springs Window Fashions, LLC, a leading supplier of blinds, shades, specialty treatments and window hardware.
• Represented Italian health care company SOFAR S.p.A. in the acquisition of its surgical robotics division by medical device company TransEnterix (NYSE MKT: TRXC) in a cash and stock deal valued at up to approximately $100 million. 
• Represented Viewfinity, a provider of privilege management and application control software, in its $30.5 million sale to Cyber Ark, a provider of IT security solutions.
• Represented Applied Genetic Technologies Corporation (NASDAQ: AGTC), a publicly traded company focused on gene therapy, in its collaboration, manufacturing and equity investment agreements with Biogen (NASDAQ: BIIB).
• Represented Advion, Inc., a manufacturer of analytical systems and consumables for the life sciences industry, in its sale to Beijing Bohui Innovation Technology Co., Ltd., a system supplier focusing on the integration of R&D, production, sales and after-sales services of in vitro diagnostic products.
• Represented Quantia, Inc., a supplier of social learning and collaboration platforms for physicians, in its sale to Physicians Interactive, Inc. (a wholly-owned subsidiary of Merck), a leading provider of digital engagement solutions for healthcare professionals and consumers.
• Advised EMC Corporation (NYSE:EMC), a global leader in enabling businesses and service providers to transform their operations and deliver information technology as a service (ItaaS), in its acquisition of Syncplicity, Inc., a leader in cloud-based file management solutions.
• Representation of Abiomed, a leading manufacturer of heart and circulatory support devices, in its acquisition of ECP Entwicklungsgesellschaft mBH and AIS GmbH Aachen Solutions.
• Represented EMC Corporation, a global leader in enabling businesses and service providers to transform their operations and deliver information technology as a service (ItaaS), in its acquisition of Renasar Technologies, Inc.
• Represented Rocket Travel, Inc., operator of hotel booking website Rocketmiles, in its sale to The Priceline Group, Inc. (NASDAQ: PCLN),  a provider of online travel & related services.
• Advised NextCODE Health, LLC, a leading genomic analysis and bioinformatics company with operations focused in the United States and Iceland, in the sale of its wholly-owned operating subsidiary, NextCODE Health Luxembourg, S.a.r.l. to WuXi Genomics, Inc. 
• Represented global investment management firm Fortress Investment Group LLC in its acquisition of MicroFinancial Incorporated (Nasdaq: MFI), a financial intermediary specializing in microticket leasing and financing^PE.
• Represented Alere Inc. (NYSE: ALR), a global diagnostics and health management company,  in its $270 million acquisition of eScreen, Inc., an automated platform and FDA-cleared reader for the collection, management and reporting of regulated and non-regulated drug screens.
• Served as lead counsel to medical diagnostics company Alere Inc. (NYSE:ALR) on the $600 million sale of its Alere Health division to healthcare company Optum.
• Represented Mill Road Capital, a private investment firm focused on investing in publicly traded micro-cap companies, in its CAD $210 million sale of Vision 7 to BlueFocus^PE.
• Represented Global Forest Partners LP in a joint venture involving an affiliate of GFP LP to acquire all of the shares of Phu Rieng Kratie Apivath Caoutchouc Co., Ltd., a Cambodian company^PE.
• Represented Mill Road Capital in its $215 million take-private acquisition of R.G. Barry Corporation^PE.
• Advised sports media company Ubersense in its acquisition by Hudl, a sports team analysis software provider.
• Represented Hittite Microwave Corporation (NASDAQ:HITT), a developer of high performance integrated circuits (ICs), modules, subsystems and instrumentation, in its $2.5 billion sale to Analog Devices, Inc. (NASDAQ: ADI).
• Represented SIE Computing Solutions, Inc., a leading provider of computer hardware and embedded solutions,  in its sale to ACS Integrated Systems, Inc. a portfolio company of RFE Investment Partners^PE.
• Represented IQuum, Inc., a leader in developing lab-in-a-tube technology, in connection with its $450 million acquisition by Swiss multi-national corporation Roche (SIX:ROG).
• Represented Organogenesis, Inc., a world leading regenerative medicine company focused in bio-active wound healing and soft tissue regeneration, in connection with its acquisition of the Dermagraft assets from Shire plc (NASDAQ:SHPG), a multinational innovator of specialty biopharmaceuticals based in the United Kingdom.
• Represented MEMSIC, Inc. (NASDAQ:MEMS), a leading MEMS solution provider, in its $88.5 million acquisition by IDG-Accel China Capital II.
• Represented OrderMotion Inc., a leader in order management solutions, in its acquisition by NetSuite Inc. (NYSE:N).
• Represented Thomas Partners Investment Management in its sale to Charles Schwab Corporation.
• Advised Iceland-based deCODE Genetics ehf, a global leader in analyzing and understanding the link between the genome and disease susceptibility, in its $415 million acquisition by Amgen Inc. (NASDAQ:AMGN).
• Represented Crossbeam, a provider of open architecture network security platforms, in its sale to private equity firm Thoma Bravo^PE.
• Represented SeraCare Life Sciences, Inc. (NASDAQ:SRLS), a global provider of products to aid the discovery, development and production of human diagnostics and therapeutics, in its acquisition by Project Plasma Holdings Corporation, an affiliate of Linden Capital Partners^PE.
• Served as counsel to WHI Solutions Inc., a leading software-as-a-service purveyor in the automotive parts industry, in its sale to eBay Inc. (NASDAQ:EBAY).

Note: PE = a transaction involving a private equity sponsor or portfolio company.